Knight Therapeutics Inc (GUD):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Knight Therapeutics Inc (GUD) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7938
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Knight Therapeutics Inc (Knight Therapeutics) is a specialty pharmaceutical company focused on acquisition, licensing, marketing and distribution of prescription, consumer health products and medical devices. Its consumer health products are used in the treatment of metabolic diseases, dermatological ailments, osteoarthritis, and pain associated with diabetic and peripheral neuropathy, among others. Knight Therapeutics offers medical devices for prostate ablation surgery and detection of peripheral arterial disease. The company develops drugs for treatment of various therapeutic areas such as bacterial conjunctivitis, oesophageal cancer, endobronchial cancer, diabetic macular edema, opioid addiction, and chronic pain and inflammation, among others. It partners with other companies to sell their products. Knight Therapeutics is headquartered in Montreal, Quebec, Canada.

Knight Therapeutics Inc (GUD) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Knight Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Knight Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Knight Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Knight Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Knight Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Knight Therapeutics Inc, Medical Equipment, Deal Details 10
Partnerships 10
3D Signatures and Plicit Capital Enters into Licensing Agreement with Knight Therapeutics 10
Knight Therapeutics Enters into Licensing Agreement with Pro Bono Bio 11
Equity Offering 12
3D Signatures Raises USD0.7 Million in Private Placement of Shares 12
Knight Therapeutics Inc – Key Competitors 13
Knight Therapeutics Inc – Key Employees 14
Knight Therapeutics Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Financial Announcements 16
May 10, 2018: Knight Reports First Quarter 2018 Results 16
Mar 15, 2018: Knight Reports 2017 Fourth Quarter and Year End Results 17
Nov 09, 2017: Knight Reports Third Quarter 2017 Results 19
Aug 10, 2017: Knight Reports Second Quarter 2017 Results 21
May 11, 2017: Knight Reports First Quarter 2017 Results 23
Mar 16, 2017: Knight Reports Fourth Quarter and Year-Ended December 31, 2016 Results 24
Corporate Communications 25
Oct 10, 2017: Knight Announces Changing of the Finance Guard 25
Feb 23, 2017: Knight Therapeutics Announces Board Change 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Knight Therapeutics Inc, Medical Equipment, Key Facts, 2017 2
Knight Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Knight Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Knight Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Knight Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Knight Therapeutics Inc, Deals By Market, 2012 to YTD 2018 8
Knight Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
3D Signatures and Plicit Capital Enters into Licensing Agreement with Knight Therapeutics 10
Knight Therapeutics Enters into Licensing Agreement with Pro Bono Bio 11
3D Signatures Raises USD0.7 Million in Private Placement of Shares 12
Knight Therapeutics Inc, Key Competitors 13
Knight Therapeutics Inc, Key Employees 14
Knight Therapeutics Inc, Subsidiaries 15

List of Figures
Knight Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Knight Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Knight Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Knight Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Knight Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Knight Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Knight Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Knight Therapeutics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Knight Therapeutics Inc (GUD):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AB-Biotics SA (ABB):製薬・医療:M&Aディール及び事業提携情報
    Summary AB-Biotics SA (AB-Biotics) is a provider of probiotics, pipeline products, specialty dietary supplements, and other functional ingredients. The company’s products comprise iron-containing ingredients, lactobacillus plantarum, probiotic products, gastrointestinal treatment products, proprieta …
  • Intralot S.A. (INLOT):企業の財務・戦略的SWOT分析
    Intralot S.A. (INLOT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Bridgestone Corporation:企業の戦略・SWOT・財務情報
    Bridgestone Corporation - Strategy, SWOT and Corporate Finance Report Summary Bridgestone Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Kala Pharmaceuticals Inc (KALA):製薬・医療:M&Aディール及び事業提携情報
    Summary Kala Pharmaceuticals Inc (Kala Pharmaceuticals) is a clinical stage pharmaceutical company that offers nanoparticle-based treatments for ocular diseases affecting both front and back of the eye. The company’s lead program MPP nanosuspension of an ophthalmic corticosteroid is under phase III …
  • Gencor Industries Inc (GENC):企業の財務・戦略的SWOT分析
    Gencor Industries Inc (GENC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Nightingale Informatix Corp (NGH)-医療機器分野:企業M&A・提携分析
    Summary Nightingale Informatix Corp (Nightingale) is a healthcare technology company that develops, markets and licenses application software and related services. The company offers practice management, billing solutions, medical records and interoperability products. It provides web based document …
  • Canadian Utilities Limited:企業の戦略・SWOT・財務分析
    Canadian Utilities Limited - Strategy, SWOT and Corporate Finance Report Summary Canadian Utilities Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Qatar Electricity & Water Company QSC (QEWS)-エネルギー分野:企業M&A・提携分析
    Summary Qatar Electricity & Water Company QSC (QEWC) is an energy utility. The company generates electricity and desalinates water. It owns and operates various power generation and water desalination stations: QEWC also has interests in all power and water companies in the country. The State of Qat …
  • Amara Holdings Ltd:戦略・SWOT・企業財務分析
    Amara Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Amara Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Trina Solar Co Ltd:企業の戦略的SWOT分析
    Trina Solar Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • BRF SA:企業のM&A・事業提携・投資動向
    BRF SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BRF SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital rais …
  • The Magstim Co Ltd:企業の戦略的SWOT分析
    The Magstim Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Trivitron Healthcare Pvt Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Trivitron Healthcare Pvt Ltd (Trivitron) is a medical technology company that provides solutions to healthcare providers. The company’s products include radiography and c-arm systems, newborn screening, mammography, ultrasound, contrast media, breast biopsy system, bone densitometer, radiati …
  • Torrent Power Limited:企業の戦略・SWOT・財務分析
    Torrent Power Limited - Strategy, SWOT and Corporate Finance Report Summary Torrent Power Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Rada Electronic Industries Ltd.:企業の戦略・SWOT・財務分析
    Rada Electronic Industries Ltd. - Strategy, SWOT and Corporate Finance Report Summary Rada Electronic Industries Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Alcon Laboratories Inc:製品パイプライン分析
    Summary Alcon Laboratories Inc (Alcon), a division of Novartis AG, develops and manufactures devices in the field of Ophthalmology. The company’s portfolio encompasses contact lenses and surgical products. Alcon’s products are used for the treatment of various conditions such as cataracts, glaucoma, …
  • Genentech Inc:企業の戦略的SWOT分析
    Genentech Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Ashland Global Holdings Inc (ASH):企業の財務・戦略的SWOT分析
    Ashland Global Holdings Inc (ASH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Alere Toxicology Plc:企業の戦略的SWOT分析
    Alere Toxicology Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Repsol SA (REP):石油・ガス:M&Aディール及び事業提携情報
    Summary Repsol SA (Repsol) is an integrated oil and gas company. It has presence across the entire value chain: exploration and production, transformation, development and marketing of energy. The company’s upstream business carries out oil and natural gas exploration and production. Its downstream …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆